Approval Year
| Substance Class |
Concept
|
| Record UNII |
4Q52C550XK
|
| Record Status |
Validated (UNII)
|
| Record Version |
|
-
Download
| Name | Type | Language | ||
|---|---|---|---|---|
|
Official Name | English | ||
|
Brand Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Code | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Code | English | ||
|
Code | English | ||
|
Common Name | English | ||
|
Code | English |
| Classification Tree | Code System | Code | ||
|---|---|---|---|---|
|
NDF-RT |
N0000175658
Created by
admin on Sat Jun 26 18:57:37 UTC 2021 , Edited by admin on Sat Jun 26 18:57:37 UTC 2021
|
||
|
EMA ASSESSMENT REPORTS |
ZEVALIN (AUTHORIZED: LYMPHOMA, FOLLICULAR)
Created by
admin on Sat Jun 26 18:57:37 UTC 2021 , Edited by admin on Sat Jun 26 18:57:37 UTC 2021
|
||
|
NDF-RT |
N0000000205
Created by
admin on Sat Jun 26 18:57:37 UTC 2021 , Edited by admin on Sat Jun 26 18:57:37 UTC 2021
|
||
|
NCI_THESAURUS |
C1512
Created by
admin on Sat Jun 26 18:57:37 UTC 2021 , Edited by admin on Sat Jun 26 18:57:37 UTC 2021
|
||
|
NDF-RT |
N0000175078
Created by
admin on Sat Jun 26 18:57:37 UTC 2021 , Edited by admin on Sat Jun 26 18:57:37 UTC 2021
|
||
|
FDA ORPHAN DRUG |
84894
Created by
admin on Sat Jun 26 18:57:37 UTC 2021 , Edited by admin on Sat Jun 26 18:57:37 UTC 2021
|
| Code System | Code | Type | Description | ||
|---|---|---|---|---|---|
|
C422802
Created by
admin on Sat Jun 26 18:57:37 UTC 2021 , Edited by admin on Sat Jun 26 18:57:37 UTC 2021
|
PRIMARY | |||
|
6777
Created by
admin on Sat Jun 26 18:57:37 UTC 2021 , Edited by admin on Sat Jun 26 18:57:37 UTC 2021
|
PRIMARY | |||
|
SUB20031
Created by
admin on Sat Jun 26 18:57:37 UTC 2021 , Edited by admin on Sat Jun 26 18:57:37 UTC 2021
|
PRIMARY | |||
|
7873
Created by
admin on Sat Jun 26 18:57:37 UTC 2021 , Edited by admin on Sat Jun 26 18:57:37 UTC 2021
|
PRIMARY | |||
|
C29981
Created by
admin on Sat Jun 26 18:57:37 UTC 2021 , Edited by admin on Sat Jun 26 18:57:37 UTC 2021
|
PRIMARY | |||
|
4984
Created by
admin on Sat Jun 26 18:57:37 UTC 2021 , Edited by admin on Sat Jun 26 18:57:37 UTC 2021
|
PRIMARY | |||
|
206181-63-7
Created by
admin on Sat Jun 26 18:57:37 UTC 2021 , Edited by admin on Sat Jun 26 18:57:37 UTC 2021
|
PRIMARY | |||
|
CHEMBL1201606
Created by
admin on Sat Jun 26 18:57:37 UTC 2021 , Edited by admin on Sat Jun 26 18:57:37 UTC 2021
|
PRIMARY | |||
|
74890578
Created by
admin on Sat Jun 26 18:57:37 UTC 2021 , Edited by admin on Sat Jun 26 18:57:37 UTC 2021
|
PRIMARY | |||
|
M6187
Created by
admin on Sat Jun 26 18:57:37 UTC 2021 , Edited by admin on Sat Jun 26 18:57:37 UTC 2021
|
PRIMARY | Merck Index | ||
|
IBRITUMOMAB TIUXETAN
Created by
admin on Sat Jun 26 18:57:37 UTC 2021 , Edited by admin on Sat Jun 26 18:57:37 UTC 2021
|
PRIMARY | |||
|
262323
Created by
admin on Sat Jun 26 18:57:37 UTC 2021 , Edited by admin on Sat Jun 26 18:57:37 UTC 2021
|
PRIMARY | RxNorm | ||
|
DB00078
Created by
admin on Sat Jun 26 18:57:37 UTC 2021 , Edited by admin on Sat Jun 26 18:57:37 UTC 2021
|
PRIMARY | |||
|
4Q52C550XK
Created by
admin on Sat Jun 26 18:57:37 UTC 2021 , Edited by admin on Sat Jun 26 18:57:37 UTC 2021
|
PRIMARY | |||
|
CHEMBL2108667
Created by
admin on Sat Jun 26 18:57:37 UTC 2021 , Edited by admin on Sat Jun 26 18:57:37 UTC 2021
|
PRIMARY |
This is a non-substance concept
| Related Record | Type | Details | ||
|---|---|---|---|---|
|
|
TARGET -> AGONIST | |||
|
TARGET->LIGAND |
BINDING
|
| Related Record | Type | Details | ||
|---|---|---|---|---|
|
|
ACTIVE MOIETY |
This is a non-substance concept